MTMT-ben szereplő publikációk tallózása szerző szerint "Huber K"

1-2 / 2

Duration of ischemia and treatment effects of pre- versus in-hospital ticagrelor in patients with ST-segment elevation myocardial infarction: Insights from the ATLANTIC study.

Bagai A; Goodman SG; Cantor WJ; Vicaut E; Bolognese L; Cequier A; Chettibi M; Hammett CJ; Huber K; Janzon M; Lapostolle F; Lassen JF; Merkely, Béla Péter; Storey RF; Ten Berg JM; Zeymer U; Diallo A; Hamm CW; Tsatsaris A; El Khoury J; Van't Hof AW; Montalescot G (2018)

BACKGROUND: Among patients with STEMI in the ATLANTIC study, pre-hospital administration of ticagrelor improved post-PCI ST-segment resolution and 30-day stent thrombosis. We investigated whether this clinical benefit with ...
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

Huber K; Connolly SJ; Kher A; Christory F; Dan GA; Kiss, Róbert Gábor; Merkely, Béla Péter (2013)

Atrial fibrillation (AF) is associated with an increased risk of thromboembolism, and is the most prevalent factor for cardioembolic stroke. Vitamin K antagonists (VKAs) have been the standard of care for stroke prevention ...

1-2 / 2

Keresés